Improved adenoviral vectors: cautious optimism for gene therapy
- PMID: 9068800
- DOI: 10.1093/qjmed/90.2.105
Improved adenoviral vectors: cautious optimism for gene therapy
Similar articles
-
Improvements in gene therapy: averting the immune response to adenoviral vectors.BioDrugs. 2002;16(1):3-10. doi: 10.2165/00063030-200216010-00001. BioDrugs. 2002. PMID: 11908997 Review.
-
Development of group B adenoviruses as gene transfer vectors.Biotechnol Genet Eng Rev. 2006;22:101-23. doi: 10.1080/02648725.2006.10648067. Biotechnol Genet Eng Rev. 2006. PMID: 18476328 Review. No abstract available.
-
Entering the Modern Era of Gene Therapy.Annu Rev Med. 2019 Jan 27;70:273-288. doi: 10.1146/annurev-med-012017-043332. Epub 2018 Nov 26. Annu Rev Med. 2019. PMID: 30477394 Review.
-
A brief account of viral vectors and their promise for gene therapy.Gene Ther. 2017 Jan;24(1):1-2. doi: 10.1038/gt.2016.71. Gene Ther. 2017. PMID: 28123184 No abstract available.
-
Adenoviral vectors for hepatic gene transfer in animals.Chest. 1997 Jun;111(6 Suppl):138S-142S. doi: 10.1378/chest.111.6_supplement.138s. Chest. 1997. PMID: 9184566 Review. No abstract available.
Cited by
-
Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2.Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8829-34. doi: 10.1073/pnas.95.15.8829. Proc Natl Acad Sci U S A. 1998. PMID: 9671764 Free PMC article.
-
Genetic targeting of the renin-angiotensin system for long-term control of hypertension.Curr Hypertens Rep. 2002 Feb;4(1):25-31. doi: 10.1007/s11906-002-0049-7. Curr Hypertens Rep. 2002. PMID: 11790288 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical